Federation des caisses Desjardins du Quebec’s Creative Medical Technology CELZ Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CELZ Stock Details CELZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$4.92K	–	2388
2023 Q3	$4.92K	Hold	1,000	–	–	﹤0.01%	1920
2023 Q2	$4.63K	Hold	1,000	–	–	﹤0.01%	1929
2023 Q1	$5K	Buy	+1,000	New	+$5.68K	﹤0.01%	1909

Other funds holding CELZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ODG

O'Dell Group Cincinnati, Ohio $466M AUM 13.5% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CELZ Position: Q4 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Creative Medical Technology (CELZ) in Q4 2023, closing a stake of 1,000 shares — an estimated $4.92K sold.

Federation des caisses Desjardins du Quebec first reported a position in CELZ in Q1 2023 and held it in 3 quarters. The position peaked at $5K in Q1 2023. 8 funds tracked by Wall St. Rank hold CELZ as of Q4 2023.

Federation des caisses Desjardins du Quebec reported no remaining Creative Medical Technology position as of Q4 2023 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,000 Creative Medical Technology shares in Q4 2023, an estimated $4.92K.
Federation des caisses Desjardins du Quebec first reported a position in Creative Medical Technology in Q1 2023 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's Creative Medical Technology position peaked at $5K in Q1 2023.
8 funds tracked by Wall St. Rank held Creative Medical Technology as of Q4 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2023, filed 15 Aug 2024.